More trials needed to determine cardiovascular outcomes… Testosterone decreases with age. Previous studies show that low concentration can predict obesity and diabetes independently. Other studies showed that a decrease in testosterone can be linked with cardiovascular mortality in elderly populations. Recent studies show that testosterone replacement treatment in patients with …

Fine particulate matter air pollution correlated with increased cardiovascular, respiratory disease… Current literature has shown that fine particulate matter air pollution is correlated with an increased risk for cardiovascular outcomes. The studies established an association with air pollution with double rates of hospital admission in patients with diabetes. A 10-month …

Elevated serum liver markers may be disease indicator…. Type 2 diabetes and liver disease seem to have a connection; the liver is one of the targets of some common diabetic medications. The body needs the liver to help maintain normal glucose levels. But when the cells in the body become …

Protein levels in pregnant women, ground fingernail clippings may lead to alternative tests…. Researchers have successfully tested two new potential methods for diagnosing and monitoring diabetes in its standard and gestational form. These tests could be easier, timelier, and more affordable for patients to identify and treat diabetes. The first …

What do alcohol consumption, smoking, obesity, and diabetes have in common… Previous studies have shown that cardiovascular risk factors are linked to cognitive decline leading to Alzheimer’s disease and dementia. However, we don’t currently have effective treatments for Alzheimer’s disease, so the focus is on prevention. Being able to understand …

Single daily injection for type 2 diabetes is mix of lixisenatide and insulin glargine…. Sanofi’s experimental drug LixiLan is a fixed-ratio single daily injection combination of Lyxumia (lixisenatide) and Lantus (insulin glargine) for patients with type 2 diabetes. It can potentially be the first combination of basal insulin and GLP-1 …

Data establishes effectiveness of semaglutide in treatment of type 2 diabetes…. Novo Nordisk is currently the manufacturer for Victoza (liraglutide), a GLP-1 agonist that needs to be injected once daily. However, semaglutide only needed to be taken once weekly, which is more preferred. The main objective of the SUSTAIN-3 trial …

Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. For postmenopausal women, said the scientists, the typical effect was increased aggression. The effect was significant for postmenopausal women older than age 45. The increase in aggression …

While undergoing laparoscopic sleeve gastrectomy induced weight loss and improvements in obesity-related disorders, long-term follow up shows significant weight regain and a decrease in remission rates of diabetes and, to a lesser extent, other obesity-related disorders over time, according to a study. Laparoscopic sleeve gastrectomy (LSG) is a common and …

Any new medications will be over $300 a month, which is one of the main reasons for higher costs for those with diabetes. The other high cost is for inpatient care. A study in Diabetes Care found that patients with diabetes had more than twice the unadjusted mean direct health …